Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 102

1.

Immune-mediated adverse effects of biologicals used in the treatment of rheumatic diseases.

Borchers AT, Leibushor N, Cheema GS, Naguwa SM, Gershwin ME.

J Autoimmun. 2011 Dec;37(4):273-88. doi: 10.1016/j.jaut.2011.08.002. Epub 2011 Sep 9. Review.

PMID:
21907543
[PubMed - indexed for MEDLINE]
2.

[Infectious risk].

Calabuig E, Salavert M.

Actas Dermosifiliogr. 2008 Jul;99 Suppl 4:14-22. Spanish.

PMID:
19080987
[PubMed - indexed for MEDLINE]
3.

Anti-TNF immunotherapy and tuberculosis reactivation: another mechanism revealed.

Miller EA, Ernst JD.

J Clin Invest. 2009 May;119(5):1079-82.

PMID:
19422095
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Tumor necrosis factor-alpha antagonists for the treatment of rheumatic diseases.

Criscione LG, St Clair EW.

Curr Opin Rheumatol. 2002 May;14(3):204-11. Review.

PMID:
11981314
[PubMed - indexed for MEDLINE]
5.

Detection of latent tuberculosis in immunosuppressed patients with autoimmune diseases: performance of a Mycobacterium tuberculosis antigen-specific interferon gamma assay.

Matulis G, Jüni P, Villiger PM, Gadola SD.

Ann Rheum Dis. 2008 Jan;67(1):84-90. Epub 2007 Jul 20.

PMID:
17644549
[PubMed - indexed for MEDLINE]
6.

Safety of etanercept in psoriasis: a critical review.

Sánchez Carazo JL, Mahiques Santos L, Oliver Martinez V.

Drug Saf. 2006;29(8):675-85. Review.

PMID:
16872241
[PubMed - indexed for MEDLINE]
7.

Anti-cytokine antibodies for rheumatic diseases.

Atzeni F, Sarzi-Puttini P.

Curr Opin Investig Drugs. 2009 Nov;10(11):1204-11. Review.

PMID:
19876788
[PubMed - indexed for MEDLINE]
8.

Anti-TNF immunotherapy reduces CD8+ T cell-mediated antimicrobial activity against Mycobacterium tuberculosis in humans.

Bruns H, Meinken C, Schauenberg P, Härter G, Kern P, Modlin RL, Antoni C, Stenger S.

J Clin Invest. 2009 May;119(5):1167-77. doi: 10.1172/JCI38482. Epub 2009 Apr 20.

PMID:
19381021
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Infectious complications with anti-TNFalpha therapy in rheumatic diseases: a review.

Toussirot E, Streit G, Wendling D.

Recent Pat Inflamm Allergy Drug Discov. 2007 Feb;1(1):39-47. Review.

PMID:
19075965
[PubMed - indexed for MEDLINE]
10.

Initiation of tumor necrosis factor α antagonists and risk of fractures in patients with selected rheumatic and autoimmune diseases.

Kawai VK, Grijalva CG, Arbogast PG, Curtis JR, Solomon DH, Delzell E, Chen L, Ouellet-Hellstrom R, Herrinton L, Liu L, Mitchell EF Jr, Stein CM, Griffin MR.

Arthritis Care Res (Hoboken). 2013 Jul;65(7):1085-94. doi: 10.1002/acr.21937.

PMID:
23281339
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Management of inflammatory bowel disease with infliximab and other anti-tumor necrosis factor alpha therapies.

Magro F, Portela F.

BioDrugs. 2010 Dec 14;24 Suppl 1:3-14. doi: 10.2165/11586290-000000000-00000. Review.

PMID:
21175228
[PubMed - indexed for MEDLINE]
12.

Long-term risks associated with biologic response modifiers used in rheumatic diseases.

Imperato AK, Smiles S, Abramson SB.

Curr Opin Rheumatol. 2004 May;16(3):199-205. Review.

PMID:
15103245
[PubMed - indexed for MEDLINE]
13.

Anti-tumor necrosis factor therapies in immune-mediated rheumatic diseases. Other observations from the clinic.

Russell AS, Rosenbaum JT.

J Rheumatol Suppl. 2010 May;85:53-62. doi: 10.3899/jrheum.091465. Review.

PMID:
20436165
[PubMed - indexed for MEDLINE]
14.

Immune-mediated side-effects of cytokines in humans.

Vial T, Descotes J.

Toxicology. 1995 Dec 20;105(1):31-57. Review.

PMID:
8638283
[PubMed - indexed for MEDLINE]
15.
16.

Usefulness of enzyme-linked immunospot assay (Elispot) compared to tuberculin skin testing for latent tuberculosis screening in rheumatic patients scheduled for anti-tumor necrosis factor treatment.

Vassilopoulos D, Stamoulis N, Hadziyannis E, Archimandritis AJ.

J Rheumatol. 2008 Jul;35(7):1271-6. Epub 2008 Mar 15.

PMID:
18381793
[PubMed - indexed for MEDLINE]
17.

Infections and autoimmune diseases.

Bach JF.

J Autoimmun. 2005;25 Suppl:74-80. Epub 2005 Nov 8. Review.

PMID:
16278064
[PubMed - indexed for MEDLINE]
18.

[Indications and adverse events with the use of anti-TNFalpha agents in pediatric rheumatology: experience of a single center].

de Oliveira SK, de Almeida RG, Fonseca AR, Rodrigues MC, Sztajnbok F, Diniz C.

Acta Reumatol Port. 2007 Apr-Jun;32(2):139-50. Portuguese.

PMID:
17572652
[PubMed - indexed for MEDLINE]
Free Article
19.

[Tuberculosis in compromised hosts].

[No authors listed]

Kekkaku. 2003 Nov;78(11):717-22. Japanese.

PMID:
14672050
[PubMed - indexed for MEDLINE]
20.

Penitentiary or penthouse condo: the tuberculous granuloma from the microbe's point of view.

Paige C, Bishai WR.

Cell Microbiol. 2010 Mar;12(3):301-9. doi: 10.1111/j.1462-5822.2009.01424.x. Epub 2009 Dec 21. Review.

PMID:
20039878
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk